Testing effectiveness (Phase 2)UnknownNCT04913025What this trial is testingREduced Frequency ImmuNE Checkpoint Inhibition in CancersWho this might be right forRenal Cell CarcinomaMelanoma University College, London 160
Early research (Phase 1)Study completedNCT01525017What this trial is testingA Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney CancerWho this might be right forMetastatic Renal Cell Carcinoma Mendus 12
Testing effectiveness (Phase 2)Ended earlyNCT04434560What this trial is testingNeoadjuvant Immunotherapy in Brain MetastasesWho this might be right forBrain Metastases, Adult Sarah Sammons, MD 1
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Not applicableStudy completedNCT00806650What this trial is testingAnti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney CancerWho this might be right forKidney Cancer City of Hope Medical Center 155
Not applicableLooking for participantsNCT05037825What this trial is testingThe Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsWho this might be right forNon-Small-Cell Lung CarcinomaMalignant MelanomaRenal Cell Carcinoma+1 more VastBiome 800
Not applicableStudy completedNCT04309617What this trial is testingRetrospective Study on Referral Patterns for High Risk Patients Post NephrectomyWho this might be right forRenal Cell Carcinoma Pfizer 618
Early research (Phase 1)Active Not RecruitingNCT07160335What this trial is testingA Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsWho this might be right forNon-small Cell Lung CancerMelanomaRenal Cell Carcinoma Shanghai Henlius Biotech 174
Not applicableEnded earlyNCT04341740What this trial is testingInvestigating Marrow Infiltrating Lymphocytes in Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaUrothelial Carcinoma University of Oklahoma 6
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64
Very early researchLooking for participantsNCT05733715What this trial is testingNeoadjuvant Pembrolizumab and Lenvatinib for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)UnknownNCT00301990What this trial is testingBevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Jonsson Comprehensive Cancer Center 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025What this trial is testingZanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 City of Hope Medical Center 34
Testing effectiveness (Phase 2)Ended earlyNCT01925118What this trial is testingIrradiated Donor Lymphocyte Infusion Plus High-dose IL-2Who this might be right forMetastatic Malignant Melanoma and Renal Cell Carcinoma Seoul National University Hospital 9
Testing effectiveness (Phase 2)UnknownNCT02429440What this trial is testingAdjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated PeptidesWho this might be right forRenal Cell CancerAdvanced Renal Cell Cancer University Hospital Tuebingen 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540What this trial is testingA Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)Who this might be right forRenal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Testing effectiveness (Phase 2)Ended earlyNCT02771626What this trial is testingStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)Who this might be right forClear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Calithera Biosciences, Inc 118
Not applicableStudy completedNCT03052504What this trial is testingProspective Versus Retrospective Complications in Radical Cystectomy and NephrectomyWho this might be right forBladder CancerRenal Cell Carcinoma Jørgen Bjerggaard Jensen 156
Not applicableLooking for participantsNCT07461090What this trial is testingLaparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost AnalysisWho this might be right forNonfunctioning KidneyRenal Cell Carcinoma (RCC) Menoufia University 60
Testing effectiveness (Phase 2)UnknownNCT05879510What this trial is testing68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 63